SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The primate lentivirus auxiliary protein Vpx counteracts an unknown restriction factor that renders human dendritic and myeloid cells largely refractory to HIV-1 infection. Here we identify SAMHD1 as this restriction factor. SAMHD1 is a protein involved in Aicardi-Goutières syndrome, a genetic encephalopathy with symptoms mimicking congenital viral infection, that has been proposed to act as a negative regulator of the interferon response. We show that Vpx induces proteasomal degradation of SAMHD1. Silencing of SAMHD1 in non-permissive cell lines alleviates HIV-1 restriction and is associated with a significant accumulation of viral DNA in infected cells. Concurrently, overexpression of SAMHD1 in sensitive cells inhibits HIV-1 infection. The putative phosphohydrolase activity of SAMHD1 is probably required for HIV-1 restriction. Vpx-mediated relief of restriction is abolished in SAMHD1-negative cells. Finally, silencing of SAMHD1 markedly increases the susceptibility of monocytic-derived dendritic cells to infection. Our results demonstrate that SAMHD1 is an antiretroviral protein expressed in cells of the myeloid lineage that inhibits an early step of the viral life cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, sterile alpha motif and HD domain 1 (SAMHD1) inhibits reverse transcription by depleting the cellular pool of deoxynucleotide triphosphates [63,64]”
From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection72,73.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [72]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Neil, S. J. D., Zang, T., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,902
The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys
Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,816
Rice, G. I., Bond, J., Asipu, A., Brunette, R. L., Manfield, I. W., Carr, I. M., Fuller, J. C., Jackson, R. M., Lamb, T., Briggs, T. A., et al. (2009) · Nature Genetics · doi:10.1038/ng.373 · Cited by 689
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Sobhian, B., Laguette, N., Yatim, A., Nakamura, M., Levy, Y., Kiernan, R., & Benkirane, M. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.04.012 · Cited by 381
Self-citationBlanchet, F. P., Moris, A., Nikolic, D. S., Lehmann, M., Cardinaud, S., Stalder, R., Garcia, E., Dinkins, C., Leuba, F., Wu, L., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.011 · Cited by 295
Self-citationImmunoaffinity Purification of Mammalian Protein Complexes
Nakatani, Y., & Ogryzko, V. (2003) · Methods in Enzymology · doi:10.1016/s0076-6879(03)70037-8 · Cited by 283
DCs and NK cells: critical effectors in the immune response to HIV-1
Altfeld, M., Fadda, L., Frleta, D., & Bhardwaj, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2935 · Cited by 216
Srivastava, S., Swanson, S. K., Manel, N., Florens, L., Washburn, M. P., & Skowronski, J. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000059 · Cited by 209
Cited by
Items 801–900 of 1,001
Vorontsov, I. I., Wu, Y., DeLucia, M., Minasov, G., Mehrens, J., Shuvalova, L., Anderson, W. F., & Ahn, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.524207 · Cited by 19
“The virulence factor Vpx in HIV-2 and simian immunodeficiency virus antagonizes SAMHD1 by directing it for proteasome-dependent degradation (9, 10, 14).”
BackgroundFukui, Y., Sasaki, E., Fuke, N., Nakai, Y., Ishijima, T., Abe, K., & Yajima, N. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000767 · Cited by 21
“the suppression of intracellular micro-organisms (Clk ((39)), SAM domain and HD domain, 1 (Samhd1)((40))), the crosspriming of CD8þ cytotoxic T cells (Hspa1b ((41)), H2-k1 and NK cell”
SAMHD1: A Novel Antiviral Factor in Intrinsic Immunity
Chen, Z., Zhang, L., & Ying, S. (2012) · Future Microbiology · doi:10.2217/fmb.12.81 · Cited by 18
Tetherin/BST-2: Restriction Factor or Immunomodulator?
Li, S. X., Barrett, B. S., Guo, K., & Santiago, M. L. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224102752 · Cited by 17
Hofmann, S., Dehn, S., Businger, R., Bolduan, S., Schneider, M., Debyser, Z., Brack‐Werner, R., & Schindler, M. (2017) · Open Biology · doi:10.1098/rsob.170115 · Cited by 19
“Vpx, which is expressed by HIV-2 and some SIVs, neutralizes the antiviral activity of the nucleotide hydrolase SAMHD1 [81,82].”
HIV-1 Tat phosphorylation on Ser-16 residue modulates HIV-1 transcription
Ivanov, A. I., Lin, X., Ammosova, T., Ilatovskiy, A. V., Kumari, N., Lassiter, H., Afangbedji, N. K. A., Niu, X., Petukhov, M., & Nekhai, S. A. (2018) · Retrovirology · doi:10.1186/s12977-018-0422-5 · Cited by 17
CR4 Signaling Contributes to a DC-Driven Enhanced Immune Response Against Complement-Opsonized HIV-1
Bermejo‐Jambrina, M., Blatzer, M., Jauregui-Onieva, P., Yordanov, T. E., Hörtnagl, P., Valovka, T., Huber, L. A., Wilflingseder, D., & Posch, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02010 · Cited by 18
“The low-Beside hiding from DC-mediated immunity by low-level infection, the virus additionally exploits DCs as shuttles to promote its own dissemination (11, 12).”
BackgroundBanchenko, S., Krupp, F., Gotthold, C., Bürger, J., Graziadei, A., O’Reilly, F. J., Sinn, L., Ruda, O., Rappsilber, J., Spahn, C. M. T., et al. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009775 · Cited by 18
“Importantly, Vpx also recruits the SAMHD1 restriction factor to DCAF1, in order to mark it for proteasomal destruction [37,38].”
BackgroundWu, Y., Koharudin, L. M. I., Mehrens, J., DeLucia, M., Byeon, C., Byeon, I. L., Calero, G. A., Ahn, J., & Gronenborn, A. M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.665513 · Cited by 18
“For example, Vpx binds DDB1- and Cullin4-associated factor 1 (DCAF1), a substrate receptor of Cullin4 RING E3 ubiquitin ligase (CRL4) and loads SAMHD1 for polyubiquitination, the first step toward degradation (10, 11, 20).”
BackgroundViral Manipulations of the Cullin-RING Ubiquitin Ligases
Liu, Y., & Tan, X. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_7 · Cited by 17
Bayliss, R., Wheeldon, J., Caucheteux, S. M., Niessen, C. M., & Piguet, V. (2020) · Journal of Virology · doi:10.1128/jvi.01597-19 · Cited by 17
Viral evasion of cGAS-STING pathway: opportunities for intervention
Yu, X., Wang, S., Ye, R., & Wei, W. (2025) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2025.08.009 · Cited by 17
Zhao, Z., Li, Z., Huan, C., Liu, X., & Zhang, W. (2021) · Journal of Virology · doi:10.1128/jvi.00620-21 · Cited by 16
“dNTPs into the constituent deoxynucleoside and inorganic triphosphate (1).”
BackgroundInterferon-inducible SAMHD1 restricts viral replication through downregulation of lipid synthesis
An, N. A., Ge, Q., Shao, H., Li, Q., Guo, F., Liang, C., Li, X., Yi, D., Yang, L., & Cen, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007718 · Cited by 19
“Subsequently, more studies indicated that SAMHD1 could be upregulated by different types of IFNs in various cells, especially in resting CD4+ T cells and myeloid cells (6).”
BackgroundSingle-cell RNA-seq analysis reveals dual sensing of HIV-1 in blood Axl+ dendritic cells
Brouiller, F., Nadalin, F., Bonté, P., Aït-Mohamed, O., Delaugerre, C., Lelièvre, J., Ginhoux, F., Ruffin, N., & Benaroch, P. (2023) · iScience · doi:10.1016/j.isci.2023.106019 · Cited by 17
“However, HIV-1 replication in myeloid cells is highly restricted by the SAMHD1 enzyme that degrades the cytosolic pool of dNTP, but is counteracted by HIV-2 coded protein Vpx (Cribier et al., 2013; Hrecka et al., 2011; Laguette et al., 2011; Lahouassa et al., 2012).”
InfluentialXu, B., Sui, Q., Hu, H., Hu, X., Zhou, X., Qian, C., & Li, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097888 · Cited by 18
Nicastro, G. G., Burroughs, A. M., Iyer, L. M., & Aravind, L. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad879 · Cited by 17
Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing
Scott, T. M., Arnold, L. M., Powers, J. A., McCann, D., Rowe, A. B., Christensen, D. E., Pereira, M. J. B., Zhou, W., Torrez, R. M., Iwasa, J., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012206 · Cited by 20
“Human monocyte-derived dendritic cells (MDDCs) and monocyte-derived macrophages (MDMs) can be infected by HIV-1, particularly when the lentiviral accessory protein Vpx is provided in trans to overcome SAMHD1-mediated restriction in MDDCs [59,60].”
Altered antigen-presenting cells during HIV-1 infection
Piguet, V., Caucheteux, S. M., Iannetta, M., & Hosmalin, A. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000096 · Cited by 17
“Because of the endogenous expression of SAMHD1, HIV-1 replication in mDC and pDC is severely limited [20].”
BackgroundLv, M., Wang, J., Zhang, J., Zhang, B., Wang, X., Zhu, Y., Zuo, T., Liu, D., Li, X., Wu, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111422 · Cited by 16
“These are the APOBEC3 family of proteins [3], BST-2 [4,5,6], TRIM5a [7,8,9] and SAMHD1 [10,11].”
BackgroundMass Spectrometry-Based Proteomic Approaches for Discovery of HIV–Host Interactions
Luo, Y., & Muesing, M. A. (2014) · Future Virology · doi:10.2217/fvl.14.86 · Cited by 17
Côté, S. C., Plante, A., Tardif, M. R., & Tremblay, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067735 · Cited by 19
“It has been recently reported that SAMHD1 represents an important restriction factor for HIV-1 in myeloid cells and resting CD4 T cells, which acts by controlling the intracellular pool of dNTPs [50,51].”
BackgroundSadewasser, A., Paki, K., Eichelbaum, K., Bogdanow, B., Saenger, S., Budt, M., Lesch, M., Hinz, K. ‐., Herrmann, A., Meyer, T. F., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.065904 · Cited by 16
Ren, H., Yin, X., Su, C., Guo, M., Wang, X., Lei, N., Lin, Y., & Wang, X. (2020) · Autophagy · doi:10.1080/15548627.2020.1846301 · Cited by 16
Disrupting Mechanisms that Regulate Genomic Repeat Elements to Combat Cancer and Drug Resistance
Kermi, C., Lau, L., Shahmirzadi, A. A., & Classon, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.826461 · Cited by 16
“SAMHD1 was initially identified as a cellular restriction factor for Human Immuno-Deficiency Virus-1 (HIV-1) in nondividing myeloid cells (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundCellular Restriction Factors of Feline Immunodeficiency Virus
Zielonka, J., & Münk, C. (2011) · Viruses · doi:10.3390/v3101986 · Cited by 19
Host–pathogen interaction in HIV infection
Chowdhury, A., & Silvestri, G. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.07.003 · Cited by 20
Revising the Role of Myeloid cells in HIV Pathogenesis
Aggarwal, A., McAllery, S., & Turville, S. G. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0149-1 · Cited by 16
Sharifi, H. J., Furuya, A. K. M., Jellinger, R. M., Nekorchuk, M. D., & de Noronha, C. M. C. (2014) · Journal of Virology · doi:10.1128/jvi.00241-14 · Cited by 16
Du, C., Liu, H., Lin, Y., Wang, X., Ma, J., Li, Y., Wang, X., & Zhou, J. (2015) · PROTEOMICS · doi:10.1002/pmic.201400279 · Cited by 17
Ménager, M. M. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160439 · Cited by 16
Mauney, C. H., Perrino, F. W., & Hollis, T. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b01038 · Cited by 16
Samri, A., Charpentier, C., Diallo, M. S., Bertine, M., Even, S., Morin, V., Oudin, A., Parizot, C., Collin, G., Hosmalin, A., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007758 · Cited by 17
Positive selection in dNTPase SAMHD1 throughout mammalian evolution
Monit, C., Morris, E. R., Ruis, C., Szafran, B., Thiltgen, G., Tsai, M.-H., Mitchison, N. A., Bishop, K. N., Stoye, J. P., Taylor, I. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908755116 · Cited by 18
Franzolin, E., Coletta, S., Ferraro, P., Pontarin, G., D'Aronco, G., Stevanoni, M., Palumbo, E., Cagnin, S., Bertoldi, L., Feltrin, E., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201902508r · Cited by 16
Maarifi, G., Lagisquet, J., Hertel, Q., Bonaventure, B., Chamontin, C., Fuchs, K. J., Moncorgé, O., Tauziet, M., Mombled, M., Papin, L., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106540 · Cited by 17
“More precisely, this anti-HIV activity was shown to act at the reverse transcription (RT) step and SAMHD1, a previously reported HIV restriction factor (Hrecka et al , 2011; Laguette et al , 2011), was seemingly not required.”
Ikumi, N. M., & Ondondo, B. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00202 · Cited by 17
Guatelli, J., Siliciano, R. F., Kuritzkes, D. R., & Richman, D. D. (2016) · ASM Press eBooks · doi:10.1128/9781555819439.ch34 · Cited by 16
Editorial: Passive aggressive avoidance of SAMHD1 restriction by HIV-1
Appelberg, K. S., & Goodenow, M. M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ce0215-044r · Cited by 16
“For example, SIV or HIV-2 encode a viral accessory protein, Vpx, that associates intracellularly with and actively targets SAMHD1 for proteasomal degradation by the host E3 ubiquitin ligase complex [1, 6].”
BackgroundThe SAM domain of mouse SAMHD1 is critical for its activation and regulation
Buzovetsky, O., Tang, C., Knecht, K. M., Antonucci, J. M., Wu, L. J., Ji, X., & Xiong, Y. (2017) · Worldwide Protein Data Bank · doi:10.2210/pdb6brg/pdb · Cited by 16
Role of Type I Interferons during Mycobacterium tuberculosis and HIV Infections
Anes, E., Azevedo‐Pereira, J. M., & Pires, D. (2024) · Biomolecules · doi:10.3390/biom14070848 · Cited by 15
“The identification of mutations in the CA protein that allow the virus to evade the action of Mx2 [96–98, SAMHD1 was identified as an HIV-1 restriction factor that blocks early-stage virus replication in dendritic cells (DCs) [110,111].”
BackgroundMcCown, C., Yu, C. H., & Ivanov, D. N. (2025) · Nature Communications · doi:10.1038/s41467-025-56208-y · Cited by 16
Determinants for degradation of SAMHD1, Mus81 and induction of G2 arrest in HIV-1 Vpr and SIVagm Vpr
DePaula-Silva, A. B., Cassiday, P. A., Chumley, J., Bosque, A., Monteiro-Filho, C. M., Mahon, C. S., Cone, K. R., Krogan, N. J., Elde, N. C., & Planelles, V. (2015) · Virology · doi:10.1016/j.virol.2014.12.040 · Cited by 15
“Vpx is encapsidated in HIV-2 and SIVmac virions and antagonizes SAMHD1 (Hrecka et al., 2011; Laguette et al., 2011).”
BackgroundInfluentialLi, Y., Kong, J., Peng, X., Hou, W., Qin, X., & Yu, X.-F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.663658 · Cited by 17
“E-mail: yuxiaofang@jlu. edu.cn. 4 The abbreviations used are: SAMHD1, sterile -motif/histidine-aspartate domain-containing protein; TCEP, tris(2-carboxyethyl)phosphine; RMSD, root mean square deviation; P-SAMHD1C, purified SAMHD1C; DSAMHD1C, dialyzed SAMHD1C; Hs-SAMHD1, Homo sapiens SAMHD1. crossmark THE JOURNAL OF BI…”
BackgroundInfluentialHertoghs, N., Geijtenbeek, T. B. H., & Ribeiro, C. M. S. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.01.001 · Cited by 16
DNA damage induces a SAMHD1-mediated block to the infection of macrophages by HIV-1
Jáuregui, P., & Landau, N. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-22432-4 · Cited by 16
Gallinaro, A., Borghi, M., Pirillo, M. F., Cecchetti, S., Bona, R., Canitano, A., Michelini, Z., Di Virgilio, A., Olvera, A., Brander, C., et al. (2020) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.013 · Cited by 15
“Taken together, these findings support the use of SIV-based IDLV as a platform for delivering improved rationally designed HIV-1 antigens for the development of HIV-1 vaccines and have the additional advantage related to the presence of the SIV-Vpx in the sIDLV, which significantly improves the transduction efficiency…”
ResultVpx enhances innate immune responses independently of SAMHD1 during HIV-1 infection
Cingöz, O., Arnow, N. D., Puig-Torrents, M., & Bannert, N. (2021) · Retrovirology · doi:10.1186/s12977-021-00548-2 · Cited by 15
HIV-2 Vpx neutralizes host restriction factor SAMHD1 to promote viral pathogenesis
Mohamed, A., Bakir, T. F., Al-Hawel, H., Alsharif, I., Bakheet, R., Kouser, L., Murugaiah, V., & Al-Mozaini, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-00415-2 · Cited by 16
Zhang, Q., Wang, S., Li, W., Yau, E. H., Hui, H., Singh, P. K., Achuthan, V., Karris, M., Engelman, A., & Rana, T. M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac464 · Cited by 16
“Included among them was the nucleotide phosphohydrolase SAMHD1 (SAM domain and HD domaincontaining protein 1), which is a well-known HIV-1 restriction factor (24,25) and, accordingly, all three SAMHD1targeting sgRNAs were significantly enriched in HIVresistant MT4 cells (Supplementary Figure S1B).”
BackgroundSmall but Highly Versatile: The Viral Accessory Protein Vpu
Volčič, M., Wiesmüller, L., & Kirchhoff, F. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-111821-100816 · Cited by 15
Saito, A., Nomaguchi, M., Kono, K., Iwatani, Y., Yokoyama, M., Yasutomi, Y., Sato, H., Shioda, T., Sugiura, W., Matano, T., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.050252-0 · Cited by 15
Musich, T., O’Connell, O., Gonzalez-Perez, M. P., Derdeyn, C. A., Peters, P. J., & Clapham, P. R. (2015) · Retrovirology · doi:10.1186/s12977-015-0141-0 · Cited by 15
“Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.”
BackgroundÁlvarez, M., Sebastián-Martín, A., García‐Marquina, G., & Menéndez‐Arias, L. (2017) · Scientific Reports · doi:10.1038/srep44834 · Cited by 15
“In myeloid cells, expression of the host factor SAMHD1 (sterile α motif and HD domain-containing protein-1) restricts HIV replication by reducing the intracellular dNTP pools, due to its deoxynucleoside triphosphate triphosphohydrolase (dNTPase) activity 14–17 .”
Jobe, O., Kim, J., Tycksen, E., Onkar, S., Michael, N. L., Alving, C. R., & Rao, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01352 · Cited by 15
A Defect in Influenza A Virus Particle Assembly Specific to Primary Human Macrophages
Bedi, S., Noda, T., Kawaoka, Y., & Ono, A. (2018) · mBio · doi:10.1128/mbio.01916-18 · Cited by 15
Zhang, Z., Zheng, L., Yu, Y., Wu, J., Yang, F., Xu, Y., Guo, Q., Wu, X., Cao, S., Cao, L., et al. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4988 · Cited by 16
“More specifically, studies on the underlying mechanisms of antiviral agents to fight infection have revealed that SAMHD1 inhibits HIV-1 infection in non-dividing cells by restricting viral reverse transcription, resulting in decreased virus activity and storage (14,15,113,114).”
BackgroundPIAS1 potentiates the anti-EBV activity of SAMHD1 through SUMOylation
Saiada, F., Zhang, K., & Li, R. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00636-y · Cited by 15
“In addition to limiting human immunodeficiency virus-1 (HIV-1) infection [1], SAMHD1 has also been shown to restrict the infection of herpesviruses [Epstein-Barr virus (EBV), human/mouse cytomegalovirus (HCMV/MCMV) and human simplex virus 1 (HSV-1) [2–7], vaccinia virus [2], human T cell leukemia virus type 1 [8], hep…”
BackgroundChiozzini, C., Arenaccio, C., Olivetta, E., Anticoli, S., Manfredi, F., Ferrantelli, F., d’Ettorre, G., Schietroma, I., Andreotti, M., & Federico, M. (2017) · Archives of Virology · doi:10.1007/s00705-017-3391-4 · Cited by 16
“transcription [5] and by degrading incoming viral RNA [6].”
BackgroundJames, C. D., Das, D., Bristol, M. L., & Morgan, I. M. (2020) · Pathogens · doi:10.3390/pathogens9060467 · Cited by 17
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
“This approach was necessary because PU.1 is the master transcriptional regulator necessary for macrophage differentiation and silencing PU.1 prior to infection results in a change in the cellular phenotype that causes resistance to HIV infection 72,73 .”
Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level
Acchioni, C., Sandini, S., Acchioni, M., & Sgarbanti, M. (2024) · Pathogens · doi:10.3390/pathogens13050349 · Cited by 16
“…from HIV-1, due to the activity of its Vpx protein on the cellular restriction factor alpha-motif (SAM) and histidine-aspartate (HD) domain-containing protein 1 (SAMHD1), inhibiting the SAMHD1-mediated hydrolysis of deoxynucleoside triphosphates (dNTPs) necessary for reverse transcription [51].”
BackgroundpiRNA Defense Against Endogenous Retroviruses
Abajorga, M. K., Yurkovetskiy, L., & Luban, J. (2024) · Viruses · doi:10.3390/v16111756 · Cited by 17
TRIM5 Acts as More Than a Retroviral Restriction Factor
de Silva, S., & Wu, L. J. (2011) · Viruses · doi:10.3390/v3071204 · Cited by 21
Host SAMHD1 Protein Promotes HIV-1 Recombination in Macrophages
Nguyen, L. A., Kim, D., Daly, M. B., Allan, K. C., & Kim, B. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.522326 · Cited by 16
“HIV-2 and simian immunodeficiency virus sooty mangabey (SIVsm) encode a viral protein X (Vpx), which targets SAMHD1 for proteasomal degradation (22, 25).”
BackgroundLin, X., Ammosova, T., Kumari, N., & Nekhai, S. A. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612823666170704123620 · Cited by 15
Breton, Y., Desrosiers, V., Ouellet, M., Deshière, A., Torresilla, C., Cohen, É. A., & Tremblay, M. J. (2019) · Journal of Virology · doi:10.1128/jvi.01871-18 · Cited by 15
“As an example, the deoxynucleotide (dNTP) triphosphohydrolase SAM domain and HD domain-containing protein 1 (better known as SAMHD1), when unphosphorylated, reduces the pool of dNTPs available for viral replication, thereby inhibiting reverse transcription of the viral genome (5, 6).”
BackgroundBinding to DCAF1 distinguishes TASOR and SAMHD1 degradation by HIV-2 Vpx
Martin, M. M., Matkovic, R., Larrous, P., Morel, M., Lasserre, A., Vauthier, V., & Margottin-Goguet, F. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009609 · Cited by 15
“At the forefront, HIV-2/SIVsmm Vpx induces the degradation of SAMHD1, relieving a block at the reverse transcription step [31,32].”
BackgroundA Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency
Röling, M. D., Sisakht, M. M., Ne, E., Moulos, P., Crespo, R., Stoszko, M., Crignis, E. D., Bodmer, H. C., Kan, T. W., Akbarzadeh, M., et al. (2021) · mBio · doi:10.1128/mbio.02980-21 · Cited by 14
“free available pool of nucleotides for reverse transcription (60).”
BackgroundRole of Protein–Lipid Interactions in Viral Entry
Nieto‐Garai, J. A., Contreras, F. ‐., Arboleya, A., & Lorizate, M. (2022) · Advanced Biology · doi:10.1002/adbi.202101264 · Cited by 15
Membrane Protein OTOF Is a Type I Interferon-Induced Entry Inhibitor of HIV-1 in Macrophages
Ding, H., Zhang, X., Zhu, Z., Wang, S., Xiong, Y., Shang, H., & Liang, G. (2022) · mBio · doi:10.1128/mbio.01738-22 · Cited by 16
Kayesh, M. E. H., Kohara, M., & Tsukiyama–Kohara, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119624 · Cited by 14
The myeloid cytokine network in AIDS pathogenesis
Mir, K. D., Mavigner, M., & Silvestri, G. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.05.009 · Cited by 16
“restriction factor was identified based on studies showing that certain strains of primate lentiviruses that encode the accessory protein Vpx can bypass the block to viral replication in myeloid cells [61–64].”
BackgroundInfluentialWang, T., Xu, Y., Zhu, H., Andrus, T., Ivanov, S. B., Pan, C., Dolores, J. S., Dann, G. C., Zhou, M., Forte, D. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065071 · Cited by 14
“(SAMHD1) [84,85].”
McCarthy, K. R., & Johnson, W. E. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004017 · Cited by 15
“SAMHD1 depletes deoxyribonucleotide triphosphate (dNTP) pools within terminally differentiated target cells, such as the macrophage, thereby starving the reverse transcription complex of dNTPs [15– 17].”
BackgroundInfluentialMacaque-tropic human immunodeficiency virus type 1: breaking out of the host restriction factors
Saito, A., & Akari, H. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00187 · Cited by 16
“…BST-2–Vpu, Nef, and Env interaction (Neil et al., 2008; Van Damme et al., 2008; Jia et al., 2009; LeTortorec and Neil, 2009; Sauter et al., 2009; Zhang et al., 2009; Serra-Moreno et al., 2011), and SAMHD1-Vpx and Vpr interaction (Hrecka et al., 2011; Laguette et al., 2011, 2012; Lim et al., 2012).”
BackgroundPingen, M., Sarrami‐Forooshani, R., Wensing, A. M. J., van Ham, P. M., Drewniak, A., Boucher, C. A., Geijtenbeek, T. B. H., & Nijhuis, M. (2014) · Retrovirology · doi:10.1186/preaccept-6069764581413424 · Cited by 18
Oguariri, R. M., Dai, L., Adelsberger, J. W., Rupert, A. W., Stevens, R. A., Yang, J., Huang, D.-W., Lempicki, R. A., Zhou, M., Baseler, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.468975 · Cited by 15
“These include HLA-type (1–4), HIV co-re- ceptor expression (5), the cytidine deaminase APOBEC3G (6, 7), tetherin (BST-2) (8), SAMHD1 (9, 10), and an array of cytokines.”
BackgroundSAMHD1 knockout mice: modeling retrovirus restriction in vivo
Wu, L. J. (2013) · Retrovirology · doi:10.1186/1742-4690-10-142 · Cited by 14
HIV/dendritic cell interaction: consequences in the pathogenesis of HIV infection.
Barroca, P., Calado, M. S., & Azevedo‐Pereira, J. M. (2014) · PubMed · Cited by 20
HIV1‐viral protein R (Vpr) mutations: associated phenotypes and relevance for clinical pathologies
Soares, R., Rocha, G., Meliço-Silvestre, A. A., & Gonçalves, T. (2016) · Reviews in Medical Virology · doi:10.1002/rmv.1889 · Cited by 14
“Indeed, Vpr and Vpx share several common features, including the assembly of an E3 Ub ligase complex composed of DCAF1 (DDB1-Cullin4-associated factor 1), previously known as Vpr-binding protein, (VprBP), DDB1 (damage-specific DNA binding protein 1), Cul4 (cullin4) and Rbx1 (ring box protein 1), also named as the CRL4…”
BackgroundInfluentialYamamoto, M., Koga, R., Fujino, H., Shimagaki, K., Ciftci, H. I., Kamo, M., Tateishi, H., Otsuka, M., & Fujita, M. (2017) · Journal of General Virology · doi:10.1099/jgv.0.000701 · Cited by 15
“In macrophages/resting T cells, Vpx plays a functional role in the proteasome degradation of anti-viral host protein SAMHD1 [12, 13].”
BackgroundKim, J. T., Chang, E., Sigal, A., & Baltimore, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189945 · Cited by 16
“Infection of mature DCs is rare due to host innate restriction factors such as SAMHD1[20].”
BackgroundGélinas, J., Gill, D. R., & Hyde, S. C. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00051-17 · Cited by 15
“SAMHD1 is a restriction factor counteracted by Vpx (43, 44) and functions as a”
BackgroundZhang, Y., Guan, X., Chen, Z., Cao, D., Kang, Z., Shen, Q., Lei, Q., Li, F., Li, H., Leghari, M. F., et al. (2018) · Poultry Science · doi:10.3382/ps/pey331 · Cited by 14
HSV-2 Cellular Programming Enables Productive HIV Infection in Dendritic Cells
Crisci, E., Svanberg, C., Ellegård, R., Khalid, M., Hellblom, J., Okuyama, K., Bhattacharya, P., Nyström, S. N., Shankar, E. M., Eriksson, K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02889 · Cited by 18
“SAMHD1 inhibits the early steps of HIV infection by limiting the viral cDNA synthesis by depleting deoxynucleotide triphosphates (dNTPs) (90) and SAMHD1 degradation by HIV-2 VPX give rise to enhanced infection of DCs and production of type I IFNs (91).”
BackgroundMacrophage Tropism in Pathogenic HIV-1 and SIV Infections
Moeser, M., Nielsen, J. R., & Joseph, S. (2020) · Viruses · doi:10.3390/v12101077 · Cited by 15
“HIV-2 and some SIV variants, including those derived from SIVsm, express the Vpx protein, which targets SAMHD1 for proteasome-mediated degradation, thus increasing viral replication in myeloid cells and in resting CD4+ T-cells [68,69].”
BackgroundIntrinsic Immune Mechanisms Restricting Human Cytomegalovirus Replication
Schilling, E.-M., Scherer, M., & Stamminger, T. (2021) · Viruses · doi:10.3390/v13020179 · Cited by 14
SAMHD1 Phosphorylation at T592 Regulates Cellular Localization and S-phase Progression
Batalis, S., Rogers, L. C., Hemphill, W. O., Mauney, C. H., Ornelles, D. A., & Hollis, T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.724870 · Cited by 14
“Vpx relies on a nuclear E3 ubiquitin ligase to target SAMHD1 for proteasomal degradation; cytoplasmic SAMHD1 does not interact with the nuclear machinery and is protected from this degradation pathway (Brandariz-Nuñez et al., 2012; Hofmann et al., 2012; Wei et al., 2012; Schaller et al., 2014).”
BackgroundInfluentialUncovering allostery and regulation in SAMHD1 through molecular dynamics simulations
Patra, K. K., Bhattacharya, A., & Bhattacharya, S. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25287 · Cited by 14
HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65
Fink, D., Cai, J., Whelan, M. V. X., Monit, C., de Motes, C. M., Towers, G. J., & Sumner, R. P. (2022) · Retrovirology · doi:10.1186/s12977-021-00586-w · Cited by 14
Les IFITM, un obstacle commun à de nombreux virus
Tartour, K., & Cimarelli, A. (2015) · médecine/sciences · doi:10.1051/medsci/20153104011 · Cited by 14
“Par la suite, Trim5 (tripartite motif 5 protein), la tétherine/Bst2 (bone marrow stromal antigen 2), SAMHD1 (SAM domain and HD domain-containing protein 1) et Mx2 ont été identifiés comme autant de facteurs pouvant inhiber le VIH [2-9, 41, 42].”
BackgroundHost Restriction of Lentiviruses and Viral Countermeasures: APOBEC3 and Vif
Jönsson, S., & Andrésdóttir, V. (2013) · Viruses · doi:10.3390/v5081934 · Cited by 14
Swann, J., Murry, J. P., & Young, J. A. T. (2016) · Virology Journal · doi:10.1186/s12985-016-0491-9 · Cited by 14
“These proteins include SAMHD1, which blocks reverse transcription in myeloid cells and resting CD4+ T cells by hydrolyzing dNTPs and/or degrading viral RNA [40–43], and APOBEC3G, which deaminates cytidine to uridine resulting in hypermutation during DNA synthesis [44, 45].”
BackgroundReply to SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity
Ryoo, J., Hwang, S.-Y., Choi, J., Oh, C., & Ahn, K. (2016) · Nature Medicine · doi:10.1038/nm.4164 · Cited by 14
Hakata, Y., Miyazawa, M., & Landau, N. R. (2014) · Virology Journal · doi:10.1186/1743-422x-11-108 · Cited by 13
“By interacting with the CRL4DCAF1 E3 ligase complex, Vpx targets sterile alpha motif domain- and HD domain-containing protein 1 (SAMHD1) for proteasomal degradation to counteract the SAMHD1mediated lentivirus restriction [36,37].”
BackgroundGenome integrity and inflammation in the nervous system
Aditi, A., & McKinnon, P. J. (2022) · DNA repair · doi:10.1016/j.dnarep.2022.103406 · Cited by 14
Host cell restriction factors of equine infectious anemia virus
Wang, X., Zhang, X., Ma, W., Li, J., & Wang, X. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.07.001 · Cited by 13
CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes
Kapitza, L., Ho, N., Kerzel, T., Frank, A. M., Thalheimer, F. B., Jamali, A., Schaser, T., Buchholz, C. J., & Hartmann, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183698 · Cited by 14
“An example is SAMHD1, which blocks early reverse transcription of LVs, especially in monocytes (41, 42).”
Farahani, E., Reinert, L. S., Narita, R., Serrero, M. C., Skouboe, M. K., van der Horst, D., Assil, S., Zhang, B., Iversen, M. B., Gutiérrez‐Jiménez, E., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113792 · Cited by 14
“19,20 These antiviral constitutive and stress-induced immune mechanisms act often independently of PRRs and the IFN system, 14 thus providing an immediate layer of host defense not associated with strong inflammation.”
Background
Metadata
- Authors
- Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Laguette, Nadine
- Benkirane, Monsef
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7353
- Pages
- 654-657
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3595993
- OpenAlex
- W2069554621
- Cited by
- 1,511
- References
- 27
- Citations by year
- 2026: 45 · 2025: 60 · 2024: 67 · 2023: 67 · 2022: 84 · 2021: 72 · 2020: 82 · 2019: 113 · 2018: 113 · 2017: 109 · 2016: 114 · 2015: 118 · 2014: 134 · 2013: 159 · 2012: 131
- FWCI
- 58.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- SAMHD1, HIV-1 restriction factors, Vpx, dendritic cells, myeloid cells, Aicardi-Goutières syndrome, proteasomal degradation, HIV-1 replication, viral DNA accumulation, phosphohydrolase activity, interferon response, HIV-2, simian immunodeficiency virus
- MeSH terms
- SAM Domain and HD Domain-Containing Protein 1, Cell Line, Dendritic Cells, DNA, Viral, HeLa Cells, Humans, Virus Replication, HIV-1, HIV Infections, U937 Cells, Monomeric GTP-Binding Proteins, Gene Silencing, Myeloid Cells, Proteasome Endopeptidase Complex, Viral Regulatory and Accessory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.